Allogene Therapeutics Ownership & Insider Activity

Allogene Therapeutics (ALLO) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 4.1% of shares outstanding. Institutional investors hold 37.0%. Over the past 90 days, insiders made 2 sales worth $112K.

Shares Outstanding

345.491M

Shares Float

312.199M

Insider Shares Owned

14.230M

Insider % Owned

4.1%

Institutional Shares Held

127.751M

Institutional % Held

37.0%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$112K total

Net Activity

Net Selling

Net Value (90d)

-$112K

Allogene Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Oct 21, 2026	Geoffrey Parker	CHIEF FINANCIAL OFFICER	SELL	36.342K	$1.34	$49K
Aug 21, 2026	Earl Douglas	SVP, GENERAL COUNSEL	SELL	29.697K	$2.12	$63K